Three-year Trends in Diagnosis of B3 Breast Lesions and Their Upgrade Rates to Malignant Lesions

Griffiths, R; Kaur, C; Alarcon, L; Szollosi, Z

Griffiths, R (corresponding author), St Georges Univ Hosp NHS Fdn Trust, Dept Cellular Pathol, Blackshaw Rd Tooting, London SW17 0QT, England.

CLINICAL BREAST CANCER, 2020; 20 (3): E353

Abstract

B3 lesions are a heterogeneous group, with differing risks of malignancy. We identified 614 B3 lesions over a 3year period (overall upgrade rate, 14.8......

Full Text Link